Instinct Science

Caleb Frankel, an emergency veterinarian, founded the company and serves as CEO. His clinical background shapes the product's focus on the treatment-sheet workflow that emergency and specialty veterinarians use during shift changes. The product team includes additional veterinarians and technicians who inform feature development based on real hospital-floor experience.

Instinct does not aim to replace practice-management software. It layers on top, targeting inpatient treatment workflows — dosing schedules, fluid-rate calculations, shift-change summaries — that traditional PMS platforms do not handle natively. The software integrates with existing systems to pull patient demographics and push billing codes.

The company focuses on emergency and specialty referral hospitals, where multi-shift inpatient care creates the highest demand for structured clinical handoffs. General practices with minimal hospitalization volume are not the core market. Expansion into specialty departments — cardiology, oncology, surgery — is underway.

Bain Capital Ventures and Norwest Venture Partners co-led the Series B round in 2023. Earlier investors include Prelude Ventures and Lachy Groom. The venture backing signals a growth-stage trajectory focused on product expansion rather than near-term liquidity events.

Instinct Science is a venture-backed operating company, not a family office. There is no publicly disclosed connection to single-family capital pools. The firm raises institutional venture funding and sells enterprise software to veterinary hospitals.